实用肿瘤学杂志 ›› 2013, Vol. 27 ›› Issue (4): 381-384.doi: 10.3969/j.issn.1002-3070.2013.04.019

• 综述 • 上一篇    

CXCR4与肝细胞肝癌转移的研究进展

胡章国1综述, 蒋国兴2审校   

  1. 1.祁阳人民医院肿瘤科(永州 426100);
    2.南华大学附属第一医院肿瘤放疗中心
  • 收稿日期:2013-01-29 出版日期:2013-08-28 发布日期:2013-08-13
  • 通讯作者: 胡章国, E-mail:h18974676997@163.com
  • 作者简介:胡章国, 男, (1976-), 硕士, 主治医师, 从事肝癌基础和临床方面的研究

The Advanced Research Between CXCR4 And The Metastasis Of Hepatocellular Carcinoma

HU Zhangguo1, JIANG Guoxing2   

  1. 1.Department of Medical Oncology, Qiyang People′s Hospital, Yongzhou 426100, China;
    2.Radiology Center, The First Affiliated Hospital of Nanhua University
  • Received:2013-01-29 Online:2013-08-28 Published:2013-08-13

摘要: 转移、复发是肝癌研究的重中之重, 近年来, 越来越多的研究资料表明趋化因子受体CXCR4(Chemokine receptor-4, CXCR4)可能在肝细胞肝癌侵袭、转移过程中扮演着重要角色, CXCR4有望成为肝细胞肝癌骨转移的预测标志之一, 本文结合国内外最新报道做一综述。

Abstract: Recurrence and metastasis are key issues in research on hepatocellular carcinoma.Recently, more and more research tell us that CXCR4 may play an important role in the invasion and metastasis of HCC, and it even could be an important predictor for the bone metastasis of HCC.In this review, we summarize the latest progress, both domestic and overseas on this research.

中图分类号: